Abstract
Objective: To determine the capacity of an armband vibratory stimulus as a mnestic cue to induce arm swing in individuals with Parkinson’s disease (PD).
Background: Decreased arm swing amplitude is a common motoric sign in Parkinsonism. Its association with reduced gait performance and fall risk is problematic. Enhancement of arm swing is suggested to improve ambulatory stability even in healthy males. Recent studies demonstrated cued arm swing can increase gait performance, reducing fall risk in individuals with PD.
Design/Methods: 24 PD individuals. Tests: Unified Parkinson’s Disease Rating Scale (UPDRS), and the Montreal Cognitive Assessment (MoCA); GAITRite system (FAP); Vicon software (Armswing Magnitude). Vibronome iPhone application administered vibratory stimuli through exercise armband. Gait performance analysis was measured using the GAITRite walkway over 2 sessions totaling 22 walks. All participants completed baseline, verbally instructed arm swing, armband-prompted walks, and a randomization of walks.
Results: There was a statistically significant increase in arm swing angles and FAP in participants who received verbal instruction (p=0.0005 and p=0.0019). There was also a significant increase in arm swing and FAP scores in armband intervention (p=0.047 and p=0.0289). The improvement seen between these two interventions was not significantly different, and were determined to be comparable (p=0.0559). There was also a clear relationship seen between a net increase in arm-swing angle and a higher FAP score.
Conclusions: The reduction in fall risk seen in both the verbal instruction and armband intervention confirms the hypothesized positive effect of armband intervention on arm swing in PD patients. This further reinforces the idea that an increase in arm swing is correlated to an improvement in gait. Additionally, when comparing improvement in FAP relative to change in magnitude of arm swing, a general decrease in FAP (increased fall risk) was seen in most patients with an arm swing less than 20 degrees.
Disclosure: Dr. Taber has nothing to disclose. Dr. Wu has nothing to disclose. Dr. Sterling has nothing to disclose. Dr. Billings has nothing to disclose. Dr. Peter has nothing to disclose. Dr. Koul has nothing to disclose. Dr. Pique has nothing to disclose. Dr. Golan has nothing to disclose. Dr. Ma has nothing to disclose. Dr. Cajuste has nothing to disclose. Dr. Bradley has nothing to disclose. Dr. Hartenstein has nothing to disclose. Dr. Maitland has nothing to disclose.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg